I agree that this site is using cookies. You can find further informations here.
X
Abbadessa, G.
115  results:
Search for persons X
?
1

Sexual dysfunction in multiple sclerosis: The impact of dif..:

Petracca, M ; Carotenuto, A ; Scandurra, C...
Multiple Sclerosis and Related Disorders.  78 (2023)  - p. 104907 , 2023
Link: https://doi.org/10.1016/..
 
?
2

161TiP A phase I/II, open-label study of an anti-ILT2 (LILR..:

Perets, R. ; Stemmer, S.M. ; Geva, R....
Immuno-Oncology and Technology.  20 (2023)  - p. 100672 , 2023
Link: https://doi.org/10.1016/..
 
?
3

SAR444245, a non‐alpha IL2, rescues chronic antigen and CAR..:

Sheikh, I. ; Choi, A. ; Reville, P. K....
Hematological Oncology.  41 (2023)  S2 - p. 515-517 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Isatuximab plus atezolizumab in patients with advanced soli..:

Simonelli, M. ; Garralda, E. ; Eskens, F....
ESMO Open.  7 (2022)  5 - p. 100562 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Paraneoplastic syndrome or immune-related adverse event? A ..:

Abbadessa, G. ; Miele, G. ; Fratta, M..
Acta Neurologica Belgica.  121 (2021)  5 - p. 1341-1342 , 2021
Link: https://doi.org/10.1007/..
 
?
6

Digital therapeutics in neurology:

Abbadessa, G. ; Brigo, F. ; Clerico, M....
Journal of Neurology.  269 (2021)  3 - p. 1209-1224 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Heidenhain variant of Creutzefeldt–Jackob disease in a pati..:

Abbadessa, G. ; Lavorgna, L. ; Miele, G...
Acta Neurologica Belgica.  120 (2020)  4 - p. 1007-1009 , 2020
Link: https://doi.org/10.1007/..
 
?
8

BMI influences CD20 kinetics in multiple sclerosis patients..:

Signoriello, E. ; Bonavita, S. ; Di Pietro, A....
Multiple Sclerosis and Related Disorders.  43 (2020)  - p. 102186 , 2020
Link: https://doi.org/10.1016/..
 
?
9

In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, ..:

Ranieri, C. ; Di Tommaso, S. ; Loconte, D. C....
neurogenetics.  19 (2018)  2 - p. 77-91 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Mitochondria from striate muscles: Novel techniques to isol..:

Popara, J. ; Femminò, S. ; Zicola, E....
Vascular Pharmacology.  103-105 (2018)  - p. 61-62 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Fake news, influencers and health-related professional part..:

Lavorgna, L. ; De Stefano, M. ; Sparaco, M....
Multiple Sclerosis and Related Disorders.  25 (2018)  - p. 175-178 , 2018
Link: https://doi.org/10.1016/..
 
?
12

AKT inhibitor ARQ 092 and sorafenib additively inhibit prog..:

Jilkova, Z.M. ; Kuyucu, A.Z. ; Kurma, K....
Journal of Hepatology.  66 (2017)  1 - p. S641 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Effect of novel AKT inhibitor ARQ 751 as single agent and i..:

Keerthi, K. ; Jilkova, Z.M. ; Roth, G.S....
Journal of Hepatology.  66 (2017)  1 - p. S459-S460 , 2017
Link: https://doi.org/10.1016/..
 
?
14

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in p..:

Papadopoulos, K P ; El-Rayes, B F ; Tolcher, A W...
British Journal of Cancer.  117 (2017)  11 - p. 1592-1599 , 2017
Link: https://doi.org/10.1038/..
 
?
15

Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib i..:

Roth, G. ; Macek-Jilkova, Z. ; Zeybek, A....
Journal of Hepatology.  64 (2016)  2 - p. S564-S565 , 2016
Link: https://doi.org/10.1016/..
 
1-15